Comprehensive Assessment of Head and Neck Cancer Survivors
NCT01222481 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2012-03-02
Summary
Cancer survivorship has dramatically improved within the last four decades and a greater number of Americans are living after cancer diagnosis. An increase in the number of survivors has highlighted the need to investigate the quality of life experienced by these survivors. While Survivorship research has improved our understanding of the challenges faced by some cancer survivors, there is a paucity of research on the functional and cognitive health status of head and neck cancer survivors.
The purpose of this study is to evaluate the functional and cognitive changes that occur in head and neck cancer patients as a result of cancer treatment, in an attempt to increase our understanding of the complex interactions between cancer treatment, comorbid health ailments and quality of life.
Conditions
Sponsors & Collaborators
-
University of Alabama at Birmingham
collaborator OTHER -
Jay F. Piccirillo, MD
lead OTHER
Principal Investigators
-
Oluwafunmilola T Okuyemi, MD · Washington University School of Medicine
-
Jay F Piccirillo, MD, FACS · Washington University School of Medicine
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
Countries
- United States
Study Locations
More Related Trials
-
A Pilot Study of Induction Chemotherapy Followed by Surgery for Locally Advanced Resectable Head and Neck Cancer
NCT01111942 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Effects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer
NCT04666428 ·Status: COMPLETED
-
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
NCT05811936 ·Status: RECRUITING ·Phase: NA
-
Health and Economic Outcomes of Two Different Follow up Strategies in Effectively Cured Advanced Head and Neck Cancer
NCT02262221 ·Status: SUSPENDED ·Phase: NA
-
Individualized Follow-Up for Head and Neck Cancer
NCT05386225 ·Status: RECRUITING
-
S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer
NCT00095641 ·Status: WITHDRAWN ·Phase: PHASE2
-
S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer
NCT00054054 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
NCT00002922 ·Status: COMPLETED ·Phase: PHASE2
-
Nasopharyngeal Carcinoma Post IMRT
NCT02597426 ·Status: ACTIVE_NOT_RECRUITING
-
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma
NCT03422536 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Swallowing Exercises on Patients Undergoing Radiation Treatment for Head and Neck Cancer
NCT01053546 ·Status: TERMINATED ·Phase: NA
-
Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer
NCT01098669 ·Status: COMPLETED
-
PaRTNer: Patient Reported Outcomes and Financial Toxicity in Head and Neck Cancer A Pilot, Survey Based Study
NCT03506451 ·Status: COMPLETED ·Phase: NA
-
Low-Carbohydrate Normocaloric Diet in Patients With Head and Neck Carcinoma (HNC)
NCT02555176 ·Status: COMPLETED ·Phase: NA
-
Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx Cancers
NCT02628912 ·Status: WITHDRAWN
-
2 Phase Use Of Educational Materials In Head And Neck Cancer Center
NCT02204631 ·Status: COMPLETED ·Phase: NA
-
Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
NCT00494182 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer
NCT00176241 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Sleep Quality in Head and Neck Cancer Patients Throughout Treatment Course
NCT05108233 ·Status: WITHDRAWN
-
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
NCT02128906 ·Status: RECRUITING ·Phase: PHASE2
-
Exercise Prehabilitation in Patients With Head and Neck Squamous-cell Carcinoma: The FIT4TREAT Trial
NCT05418842 ·Status: COMPLETED ·Phase: NA
-
Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer
NCT00855764 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT01154920 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT02277184 ·Status: TERMINATED ·Phase: PHASE1
-
Developing a Checklist of Lymphedema Symptoms in Patients With Head and Neck Cancer
NCT00840814 ·Status: COMPLETED